IDH wildtype was also consistent with PTRF upregulation and PTRF expression was lowest in IDH-mutated low-grade gliomas, suggesting that high PTRF mRNA expression level was associated with IDH-related immune response and a poor prognosis. The gene discussed is IDH1; the disease is central nervous system cancer.